Patent intelligence · WO
WO 02057483
NOUVEAU DOSAGE
NOUVEAU DOSAGE
Patent details — WO 02057483
- Jurisdiction
- WO
- Status
- expired
- Grant date
- Jul 25, 2002
- Expiration
- Jul 20, 2022
- Applicant
- GLAXO GROUP LTD [GB]
- CPC classes
- A61K38/00, A61P 25/ 00 A I, A61P 35/ 00 A I, A61P/2500
Quick answer
WO 02057483 (NOUVEAU DOSAGE) is held by GLAXO GROUP LTD [GB]. Status: expired. Granted Jul 25, 2002. Expires Jul 20, 2022 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- GLAXO GROUP LTD [GB]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K38/00, A61P 25/ 00 A I, A61P 35/ 00 A I, A61P/2500, A61P/3500, A61P25/00
More from GLAXO GROUP LTD [GB]
Related pharmaceutical patents in our USPTO index.
-
SA 92120308
تركيبة للاستخدام الموضعي topical composition
expired -
AT E269330
CHEMISCHE VERBINDUNGEN
expired -
EP 1425277
HARNSTOFF-DERIVATE ALS VANILLOID-REZEPTOR-ANTAGONISTEN FÜR DIE SCHMERZBEHANDLUNG
expired -
SA 91110341
مستحضر موضعي لعلاج العدوى بفيروس الحلا (القوباء) Herpesvirus
expired -
HU P0302480
PYRIDINONE DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
expired -
AT E245157
3,9-DIAZABICYCLO-(3.3.1)-NONANYLDERIVATE, VERFAHREN UND INTERMEDIATE FÜR IHRE DARSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
expired -
HK 1004528
Dentifrice compositions
expired -
HU P0204410
PYRIMIDINE-4-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE
expired
Frequently asked questions
What is US patent 02057483?
WO 02057483 (NOUVEAU DOSAGE) is held by GLAXO GROUP LTD [GB]. Status: expired. Granted Jul 25, 2002. Expires Jul 20, 2022 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns WO 02057483?
GLAXO GROUP LTD [GB] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does WO 02057483 expire?
Our index shows an expiration date of Jul 20, 2022 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.